First human doses of experimental drug given in safety trial
NCT ID NCT04589403
Summary
This was the first study to test a new drug called OPT101 in people. It aimed to find a safe dose and see how the body processes it. The study involved 14 healthy volunteers who received either the drug or a placebo. Researchers closely monitored participants for any side effects and measured drug levels in the blood.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
IMMUNOe Research
Centennial, Colorado, 80112, United States
Conditions
Explore the condition pages connected to this study.